EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Metformin Plus Insulin Versus Insulin-Only in Preventing Pre-Eclampsia in Pregnant Women with Gestational Diabetes Mellitus: A Randomized Single-Blind Clinical Trial

Sedigheh Javaheri Koupaei, Farinaz Farahbod, Minoo Movahedi, Elahe Zarean, Somayeh Khanjani, Azar Danesh Shahraki, Amirmehdi Najarnejad

Journal of Shahrekord University of Medical Sciences · 2025

DOI: 10.34172/jsums.1057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Shahrekord University of Medical Sciences, 2025. Verfasst von Sedigheh Javaheri Koupaei und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims: Gestational Diabetes Mellitus (GDM) is associated with an increased risk of pregnancy complications. The present study aimed to evaluate the effect of combined metformin and insulin therapy compared to insulin alone in preventing pre-eclampsia among pregnant women with GDM.

Methods

This randomized interventional clinical trial was conducted on 150 women with GDM in Isfahan from 2021 to 2023. Women in the insulin-only group received intermediate-acting insulin such as Neutral Protamine Hagedorn (NPH), at a dose of 0.2 units/kg. In the group treated with metformin p l u s insulin, a similar method was used, starting with an initial dose of 500 mg of metformin twice daily. The results were analyzed using SPSS software version 19.

Results

The number of patients with protein excretion in the insulin group was significantly higher than that in the insulin-plus-metformin group (P=0.006). Additionally, the insulin dose used in the insulin-plus-metformin group was significantly lower than in the insulin-only group (P=0.013). A significant difference was observed in the gestational age at study entry in patients with other pregnancy complications (P=0.04).

Conclusion

Adding metformin to insulin therapy in pregnant women with GDM may help reduce insulin requirements and the incidence of proteinuria in those who develop pre-eclampsia, without increasing other pregnancy complications.

Zitieren

APA

Koupaei, S. J., Farahbod, F., Movahedi, M., Zarean, E., Khanjani, S., Shahraki, A. D., & Najarnejad, A. (2025). Evaluation of Metformin Plus Insulin Versus Insulin-Only in Preventing Pre-Eclampsia in Pregnant Women with Gestational Diabetes Mellitus: A Randomized Single-Blind Clinical Trial. Journal of Shahrekord University of Medical Sciences. https://doi.org/10.34172/jsums.1057

Vancouver

Koupaei SJ, Farahbod F, Movahedi M, Zarean E, Khanjani S, Shahraki AD, et al. Evaluation of Metformin Plus Insulin Versus Insulin-Only in Preventing Pre-Eclampsia in Pregnant Women with Gestational Diabetes Mellitus: A Randomized Single-Blind Clinical Trial. Journal of Shahrekord University of Medical Sciences. 2025. doi:10.34172/jsums.1057

BibTeX
@article{Koupaei2025,
  author = {Koupaei, Sedigheh Javaheri and Farahbod, Farinaz and Movahedi, Minoo and Zarean, Elahe and Khanjani, Somayeh and Shahraki, Azar Danesh and Najarnejad, Amirmehdi},
  title = {Evaluation of Metformin Plus Insulin Versus Insulin-Only in Preventing Pre-Eclampsia in Pregnant Women with Gestational Diabetes Mellitus: A Randomized Single-Blind Clinical Trial},
  journal = {Journal of Shahrekord University of Medical Sciences},
  year = {2025},
  doi = {10.34172/jsums.1057}
}
Kostenlos starten →